Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Huaying Sheng, Lisha Ying, Lei Zheng, Dan Zhang, Chihong Zhu, Junzhou Wu, Jianguo Feng & Dan Su. (2015) Down Expression of FBP1 Is a Negative Prognostic Factor for Non–Small-Cell Lung Cancer. Cancer Investigation 33:5, pages 197-204.
Read now
Read now
Articles from other publishers (25)
Xueli Nan, Chao Xie, Qingqing Zhu, Jianjun Zhang, Shuai Fu, Xiao Han, Qiujing Zhang, Baohui Han & Jie Liu. (2020) Hand-foot syndrome and survival in patients with advanced non-small-cell lung cancer receiving anlotinib: a subgroup analysis of data from the ALTER 0303 study. International Journal of Clinical Oncology 25:8, pages 1492-1498.
Crossref
Crossref
Montserrat Climent, Giacomo Viggiani, Ya-Wen Chen, Gerald Coulis & Alessandra Castaldi. (2020) MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases. International Journal of Molecular Sciences 21:12, pages 4370.
Crossref
Crossref
Lanxiang Ma, Jie Du, Yongjie Sui & Shuili Wang. (2019) Clinical significance of plasma free DNA in patients with non-small cell lung cancer. Journal of International Medical Research 47:11, pages 5593-5600.
Crossref
Crossref
Baohui Han, Kai Li, Qiming Wang, Li Zhang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Yizhuo Zhao, Hao Yu, Yang Zhao, Weiqiang Chen, Yi Luo, Lin Wu, Xiuwen Wang, Robert Pirker, Kejun Nan, Faguang Jin, Jian Dong, Baolan Li & Yan Sun. (2018) Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer. JAMA Oncology 4:11, pages 1569.
Crossref
Crossref
Han Na Kang, Jae Woo Choi, Hyo Sup Shim, Jinna Kim, Dae Joon Kim, Chang Young Lee, Min Hee Hong, Seong Yong Park, A-Young Park, Eun Joo Shin, Seo Yoon Lee, Kyoung-Ho Pyo, Mi Ran Yun, Hun Mi Choi, Sung Sook Lee, Seok-Young Kim, Hanna Lee, Soonmyung Paik, Byoung Chul Cho, Jin Gu Lee & Hye Ryun Kim. (2018) Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation. Lung Cancer 124, pages 168-178.
Crossref
Crossref
Chin-Chou Wang, Chia-Cheng Tseng, Huang-Chih Chang, Kuo-Tung Huang, Wen-Feng Fang, Yu-Mu Chen, Cheng-Ta Yang, Chang-Chun Hsiao, Meng-Chih Lin, Chi-Kung Ho & Hon-Kan Yip. (2017) Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients. Oncotarget 8:44, pages 75952-75967.
Crossref
Crossref
Madhusmita Behera, Taofeek K. Owonikoko, Anthony A. Gal, Conor E. Steuer, Sungjin Kim, Rathi N. Pillai, Fadlo R. Khuri, Suresh S. Ramalingam & Gabriel L. Sica. (2016) Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma. Clinical Lung Cancer 17:5, pages e57-e64.
Crossref
Crossref
Chia-Cheng Tseng, Chin-Chou Wang, Chang-Chun Hsiao, Hung-I Lu, Steve Leu, Huang-Chih Chang, Kuo-Tung Huang, Wen-Feng Fang, Yu-Mu Chen, Shih-Feng Liu, Cheng-Ta Yang, Meng-Chih Lin & Hon-Kan Yip. (2016) Time courses and value of circulating microparticles in patients with operable stage non-small cell lung cancer undergoing surgical intervention. Tumor Biology 37:9, pages 11873-11882.
Crossref
Crossref
Juan Zhang, Jiangtao Wang, Hui Xing, Qingfeng Li, Qianfeng Zhao & Jing Li. (2015) Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells. Molecular and Cellular Biochemistry 411:1-2, pages 331-340.
Crossref
Crossref
Baocai Liu, Yu Su, Ting Li, Wanqiong Yuan, Xiaoning Mo, Henan Li, Qihua He, Dalong Ma & Wenling Han. (2015) CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation. Oncotarget 6:38, pages 41092-41107.
Crossref
Crossref
Jiunn-Jye Sheu, Fan-Yen Lee, Christopher Glenn Wallace, Tzu-Hsien Tsai, Steve Leu, Yung-Lung Chen, Han-Tan Chai, Hung-I Lu, Cheuk-Kwan Sun & Hon-Kan Yip. (2015) Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia. Journal of Translational Medicine 13:1.
Crossref
Crossref
Tamara Mirzapoiazova, Nurbek Mambetsariev, Frances E. Lennon, Bolot Mambetsariev, Joshua E. Berlind, Ravi Salgia & Patrick A. Singleton. (2015) HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression. Frontiers in Oncology 5.
Crossref
Crossref
Sara Pignatta, Isabella Orienti, Mirella Falconi, Gabriella Teti, Chiara Arienti, Laura Medri, Michele Zanoni, Silvia Carloni, Wainer Zoli, Dino Amadori & Anna Tesei. (2015) Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer. Nanomedicine: Nanotechnology, Biology and Medicine 11:2, pages 263-273.
Crossref
Crossref
Frances E. Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, Valeriy A. Poroyko, Ravi Salgia, Jonathan Moss & Patrick A. Singleton. (2014) The Mu Opioid Receptor Promotes Opioid and Growth Factor-Induced Proliferation, Migration and Epithelial Mesenchymal Transition (EMT) in Human Lung Cancer. PLoS ONE 9:3, pages e91577.
Crossref
Crossref
Qiong Wang, Shaoqing Shi, Weiyang He, Mabel T. Padilla, Lin Zhang, Xia Wang, Bin Zhang & Yong Lin. (2014) Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition. Oncotarget 5:5, pages 1304-1314.
Crossref
Crossref
Qiong Wang, Wenshu Chen, Lang Bai, Wenjie Chen, Mabel T. Padilla, Amy S. Lin, Shaoqing Shi, Xia Wang & Yong Lin. (2014) Receptor-interacting Protein 1 Increases Chemoresistance by Maintaining Inhibitor of Apoptosis Protein Levels and Reducing Reactive Oxygen Species through a microRNA-146a-mediated Catalase Pathway. Journal of Biological Chemistry 289:9, pages 5654-5663.
Crossref
Crossref
Chin-Chou Wang, Chia-Cheng Tseng, Chang-Chun Hsiao, Huang-Chih Chang, Li-Teh Chang, Wen-Feng Fang, Steve Leu, Yi-Hsi Wang, Tzu-Hsien Tsai, Cheng-Ta Yang, Chih-Hung Chen, Hon-Kan Yip, Chi-Kung Ho & Meng-Chih Lin. (2014) Circulating Endothelial-Derived Activated Microparticle: A Useful Biomarker for Predicting One-Year Mortality in Patients with Advanced Non-Small Cell Lung Cancer. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Xu-chao Zhang, Jingchuan Zhang, Ming Li, Xiao-sui Huang, Xue-ning Yang, Wen-zhao Zhong, Liang Xie, Lin Zhang, Minhua Zhou, Paul Gavine, Xinying Su, Li Zheng, Guanshan Zhu, Ping Zhan, Qunsheng Ji & Yi-long Wu. (2013) Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies. Journal of Translational Medicine 11:1.
Crossref
Crossref
Luis Paz-Ares, Beatrix Bálint, Richard H. de Boer, Jan P. van Meerbeeck, Rafal Wierzbicki, Paul De Souza, Francesco Galimi, Vincent Haddad, Tony Sabin, Yong-jiang Hei, Yang Pan, Susan Cottrell, Cheng-Pang Hsu & Rodryg RamLau. (2013) A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology 8:3, pages 329-337.
Crossref
Crossref
Massimo Di Maio, Emilio Bria, Giuseppe L. Banna, Fabio Puglisi, Marina C. Garassino, Domenica Lorusso & Francesco Perrone. (2013) Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors. Anti-Cancer Drugs 24:2, pages 99-111.
Crossref
Crossref
Shengxiang Ren, Xiaoxia Chen, Peng Kuang, Limou Zheng, Chunxia Su, Jiayu Li, Bing Li, Yongshen Wang, Lu Liu, Qiong Hu, Jie Zhang, Liang Tang, Xuefei Li, Caicun Zhou & Gerald Schmid-Bindert. (2012)
Association of
EGFR
mutation or
ALK
rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma
. Cancer 118:22, pages 5588-5594.
Crossref
Crossref
Yan-li Nie, Ke-xin Liu, Xuan-yue Mao, Yu-lin Li, Jing Li & Ming-ming Zhang. (2012) Effect of injection of brucea javanica oil emulsion plus chemoradiotherapy for lung cancer: a review of clinical evidence. Journal of Evidence-Based Medicine 5:4, pages 216-225.
Crossref
Crossref
Steven I. Robinson & Timothy J. Moynihan. (2012) Targeting the Symptoms of Lung Cancer, Not Just the Disease. The Journal of Supportive Oncology 10:1, pages 10-11.
Crossref
Crossref
V Morello, S Cabodi, S Sigismund, M P Camacho-Leal, D Repetto, M Volante, M Papotti, E Turco & P Defilippi. (2011) β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells. Oncogene 30:39, pages 4087-4096.
Crossref
Crossref
Bing-Hung Chen, Hsueh-Wei Chang, Hsuan-Min Huang, Inn-Wen Chong, Jia-Shing Chen, Chung-Yi ChenHui-Min Wang. (2011) (−)-Anonaine Induces DNA Damage and Inhibits Growth and Migration of Human Lung Carcinoma H1299 Cells. Journal of Agricultural and Food Chemistry 59:6, pages 2284-2290.
Crossref
Crossref